Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure- Rationale and design of a prospective, randomized trial (the UNIVERSE study).pdf
Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. (to be uploaded)
Cardiac performance assessment during cardiopulmonary exercise test can improve the management of children with repaired congenital heart disease. (to be uploaded)
Phenotype and outcome of PAH patients carrying a TBX4 mutation.
Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study. (to be uploaded)
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort. (to be uploaded)
Administration of gamma-hydroxybutyrate instead of beta- hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy- A case report on a medication prescribing error.pdf
Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study. (to be uploaded)
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.